§ CERTIFICATE OF ANALYSIS · THIRD-PARTY HPLC · MAR-2026● VERIFIED SUBMISSION · PUBLIC RECORD

Home › Lab Tests › VANDL Labs, Tirzepatide

◆ Batch ID · GP2.04.01.120✓ Verified · Pass

Tirzepatide × VANDL Labs - Lab Test, March 2026

Tested Monday, March 30, 2026 · submitted by @Frank 👑 Legend

HPLC Purity

99.80%

✓ Excellent

PeptideTirzepatide

Brandvandl-labs.com

LabVanguard Laboratory

↓ Download COA 🔗 Share

Test results

7 data points

Purity

99.80%

Endotoxins

Not tested

Stated qty

120 mg

Tested qty

113.74 mg

Qty match

95% of labeled · -5%

Batch ID

GP2.04.01.120

Container

Black Label / Black Cap

Tested by

Vanguard LaboratoryView profile →

◆ Quantity verification

120 mg→113.74 mg-5%

About this test

This independent HPLC-UV/VIS lab test confirms Tirzepatide 120mg from VANDL Labs at 99.80% purity. Multiple vial analysis measured 113.74 mg (highest individual vial result), conducted by Vanguard Laboratory on March 30, 2026.

Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, glycemic control, and glucose homeostasis. It is studied for its synergistic effects on both GIP and GLP-1 signaling pathways. The 99.80% purity indicates high-quality synthesis with minimal contamination.

The full certificate of analysis is available for download on this page.